Table II.
Response to therapy in the patients.
| Case no. | Pre-operative management of renal dysfunction | Post-operative and prior to acute rejection medication intravenous drip | Oral medication (post-operative and prior to acute rejection) | Following acute rejection medication administration via intravenous drip |
|---|---|---|---|---|
| 1 | Hemodialysis | Anti-human T Lymphocyte Porcine Immunoglobulin | Tacrolimus (3.5 mg, 2 times/day) | Methylprednisolone (500 mg/day, 2 days) |
| (Surgery and post1-2, 500 mg/day; post3-7, 250 mg/day) | Mycophenolate sodium enteric-coated | Anti-human T Lymphocyte Porcine | ||
| Methylprednisolone (Surgery and post1-2, 500 mg/day) | tablets (360 mg, 2 times/day) | Immunoglobulin (500 mg/day, 5 days) | ||
| Mycophenolate mofetil (Post1-2, 1,000 mg, 2 times/day) | Methylprednisolone (8 mg/day) | |||
| 2 | Hemodialysis | Anti-human T Lymphocyte Rabbit Immunoglobulin | Tacrolimus (3.0 mg morning, 3.5 mg night) | Anti-human T Lymphocyte Rabbit |
| (Surgery and post1-2, 500 mg/day; post3-7, 250 mg/day) | Mycophenolate mofetil (750 mg, 2 times/day) | Immunoglobulin (500 mg/day, 4 days) | ||
| Methylprednisolone (Surgery and post1-2, 500 mg/day) | Methylprednisolone (16 mg/day) | |||
| Mycophenolate mofetil (Post1-2, 1,000 mg/day) | ||||
| 3 | Hemodialysis | Anti-human T Lymphocyte Porcine Immunoglobulin | Tacrolimus (3.0 mg, 2 times/day) | Methylprednisolone (500 mg/day, 3 days) |
| (Surgery and post1-2, 500 mg/day; post3-7, 250 mg/day) | Mycophenolate mofetil (750 mg, 2 times/day) | |||
| Methylprednisolone (Surgery and post1-2, 500 mg/day) | Methylprednisolone (16 mg/day) | |||
| Mycophenolate mofetil (Post1-2, 1,000 mg, 2 times/day) |
Pre2, 2 days prior to transplantation.